fda warning letters compounded semaglutide 2025 september 8, 2025: launches an import alert listing safe GLP-1 manufacturers – Partnership for Safe Medicines FDA warns against compounded GLP-1

Even though the needle in these pens often retracts after use, the device still contains a medical needle that may carry traces of medication or biological material

Jiao X, Peng X, Jin X, Liu N, Yu Y, Liu R, et al

FIGURE 1 Group 1: Normal/Sham-irradiated (vehicle treatment): This group was given double distilled water (DDW) through oral gavages once in a day for 7 consecutive days (dose equivalent to CRE)

In this report, we cover: The Manufacturers and Supply Chain A Second Time Around for Second-Order Effects Ongoing Therapeutic Innovations & Clinical Data Review

Its GLP-1 formulation platform covers sweeteners, fibers, and fortification solutions